These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12176425)

  • 21. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
    Schuurman HJ; Schuler W; Ringers J; Jonker M
    Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
    [No Abstract]   [Full Text] [Related]  

  • 22. Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model.
    Grochowicz PM; Hibberd AD; Bowen KM; Clark DA; Pang G; Cowden WB; Chou TC; Grochowicz LK; Smart YC
    Transplant Proc; 1997; 29(1-2):1259-60. PubMed ID: 9123296
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
    Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.
    Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Omura T; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1208-9. PubMed ID: 10083540
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
    Loss GE; Grewal HP; Siegel CT; Peace D; Mead J; Bruce DS; Cronin DC; Millis JM; Newell KA; Woodle ES
    Transplant Proc; 1998 Jun; 30(4):1249-50. PubMed ID: 9636508
    [No Abstract]   [Full Text] [Related]  

  • 26. Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.
    Diekmann F; Waiser J; Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2001; 33(7-8):3234-5. PubMed ID: 11750386
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergism of castanospermine and FK 506.
    Grochowicz PM; Hibberd AD; Bowen KM; Clark DA; Pang G; Grochowicz LK; Willenborg DO; Cowden WB
    Transplant Proc; 1995 Feb; 27(1):355-6. PubMed ID: 7533408
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination of the adverse effects of tacrolimus-based induction therapy by a 5-day exposure of optimal steady-state blood concentration in renal transplant patients in the early postoperative period.
    Ishibashi M; Miyamoto S; Nojima M; Yoshimoto T; Yabumoto H; Mori Y; Shima H
    Transplant Proc; 1999 Nov; 31(7):2761-2. PubMed ID: 10578281
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
    Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
    Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
    [No Abstract]   [Full Text] [Related]  

  • 30. Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report.
    Morris-Stiff G; Baboolal K; Singh J; Balaji V; Ostrowski K; Moore R; Lord R; Jurewicz A
    Transplant Proc; 1998 Jun; 30(4):1245-6. PubMed ID: 9636506
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A; Plenter R; Francis DM; Clunie GJ
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 34. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
    Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients.
    Shinozuka N; Koyama I; Omoto R; Burdick J
    Transplant Proc; 1996 Jun; 28(3):1259. PubMed ID: 8658649
    [No Abstract]   [Full Text] [Related]  

  • 37. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary results of short-term combination immunosuppressions of mizoribine, azathioprine, and prednisolone with pretreatment to canine kidney transplantation.
    Minami T; Watanabe T; Muto M; Wakao Y; Suzuki T; Takahashi M
    J Vet Med Sci; 1993 Jun; 55(3):409-14. PubMed ID: 8357913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for Bradycardia.
    Okimoto A; Yamamoto R; Hirose J; Shimatani K; Koshika T; Maeda M; Hattori K; Morokata T
    Transplant Proc; 2019; 51(6):2081-2098. PubMed ID: 31399186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
    Shimmura H; Tanabe K; Habiro K; Abe R; Toma H
    Transplantation; 2006 Jul; 82(2):175-9. PubMed ID: 16858279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.